DK0569383T3 - Low molecular weight, sulfated poly-beta-2,6-fructofuranosans and their use in the treatment of degenerative joint diseases - Google Patents

Low molecular weight, sulfated poly-beta-2,6-fructofuranosans and their use in the treatment of degenerative joint diseases

Info

Publication number
DK0569383T3
DK0569383T3 DK92902125.1T DK92902125T DK0569383T3 DK 0569383 T3 DK0569383 T3 DK 0569383T3 DK 92902125 T DK92902125 T DK 92902125T DK 0569383 T3 DK0569383 T3 DK 0569383T3
Authority
DK
Denmark
Prior art keywords
beta
treatment
fructofuranosans
molecular weight
low molecular
Prior art date
Application number
DK92902125.1T
Other languages
Danish (da)
Inventor
Werner Thorwart
Horst Groetsch
Rudolf Schleyerbach
Ruth Raiss
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Application granted granted Critical
Publication of DK0569383T3 publication Critical patent/DK0569383T3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0051Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Fructofuranans, e.g. beta-2,6-D-fructofuranan, i.e. levan; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polyethers (AREA)

Abstract

The invention concerns low-molecular sulphated poly- beta -2,6-fructofuranosanes containing monomer units of formula (I), as well as their use for the prophylaxis and treatment of degenerative articular ailments.
DK92902125.1T 1991-01-30 1992-01-15 Low molecular weight, sulfated poly-beta-2,6-fructofuranosans and their use in the treatment of degenerative joint diseases DK0569383T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4102675 1991-01-30

Publications (1)

Publication Number Publication Date
DK0569383T3 true DK0569383T3 (en) 1996-10-14

Family

ID=6423977

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92902125.1T DK0569383T3 (en) 1991-01-30 1992-01-15 Low molecular weight, sulfated poly-beta-2,6-fructofuranosans and their use in the treatment of degenerative joint diseases

Country Status (16)

Country Link
EP (1) EP0569383B1 (en)
JP (1) JPH06504561A (en)
KR (1) KR930703364A (en)
AT (1) ATE138939T1 (en)
AU (1) AU1162592A (en)
CA (1) CA2101630A1 (en)
CZ (1) CZ152993A3 (en)
DE (1) DE59206499D1 (en)
DK (1) DK0569383T3 (en)
ES (1) ES2088571T3 (en)
FI (1) FI933386A0 (en)
GR (1) GR3020232T3 (en)
HU (1) HUT64935A (en)
NO (1) NO932734L (en)
WO (1) WO1992013895A1 (en)
ZA (1) ZA92603B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2811572B1 (en) 2000-07-17 2003-04-18 Adir USE OF POLYSULFATED CYCLODEXTRINS FOR THE TREATMENT OF ARTHROSIS

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB796737A (en) * 1954-09-10 1958-06-18 Hoffmann La Roche A process for the production of glycan poly-(sulphuric acid esters)
GB879133A (en) * 1958-11-24 1961-10-04 Scholten Chemische Fab Derivatives of polysaccharides which are soluble or dispersible in cold or hot water
DE1300668B (en) * 1964-01-11 1969-08-07 Hoechst Ag Process for the production of low molecular weight sulfuric acid esters from Laevanen
WO1988007060A1 (en) * 1987-03-19 1988-09-22 Arthropharm Pty. Limited Anti-inflammatory compounds and compositions

Also Published As

Publication number Publication date
HUT64935A (en) 1994-03-28
CZ152993A3 (en) 1994-02-16
GR3020232T3 (en) 1996-09-30
JPH06504561A (en) 1994-05-26
ATE138939T1 (en) 1996-06-15
ES2088571T3 (en) 1996-08-16
FI933386A (en) 1993-07-28
FI933386A0 (en) 1993-07-28
HU9302211D0 (en) 1993-10-28
KR930703364A (en) 1993-11-29
AU1162592A (en) 1992-09-07
NO932734L (en) 1993-09-13
DE59206499D1 (en) 1996-07-11
EP0569383A1 (en) 1993-11-18
ZA92603B (en) 1992-09-30
CA2101630A1 (en) 1992-07-31
EP0569383B1 (en) 1996-06-05
WO1992013895A1 (en) 1992-08-20
NO932734D0 (en) 1993-07-29

Similar Documents

Publication Publication Date Title
DK0534859T3 (en) 3-Benzazepin-2-ones which are substituted by a benzocyclobutyl or indanylalkylaminoalkyl group and are useful for the treatment of cardiovascular disease
BR0100046A (en) Water-soluble or water-swellable cross-linked copolymers
DK0579640T3 (en) Glial mitogenic factors as well as their preparation and use
ATE245977T1 (en) THERAPEUTIC SUBSTITUTED GUANIDINES
DK0386997T3 (en) Use of 4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine derivatives in the treatment of psychosis, inflammation and as immunosuppressants
DK0517104T3 (en) 1,3,5-triazine derivatives as well as their preparation and use as solar filters
EE03969B1 (en) (Methylsulfonyl) phenyl-2- (5H) -furanones, their Use and Pharmaceutical Compositions
DK0844869T3 (en) ULMWH (ultra low molecular weight heparin) for the treatment of asthma
DE69230140D1 (en) ANTIVIRAL NUCLEOSIDE COMBINATION
IT1304904B1 (en) ANTICOLINESTERASIC DERIVATIVES FOR THE TREATMENT OF FUNCTIONAL AND / OR ORGANIC SYNDROME
DK1237549T3 (en) Lipoxin A4 and its analogues for the treatment of dry eyes
DK1097173T3 (en) Use of IL-2 peptides and derivatives thereof as therapeutic agents
AR009089A1 (en) COLOR CARE COMPOSITIONS INCLUDING A DYE FIXING AGENT AND A POLYMER AND METHOD FOR PROVIDING COLOR CARE
NO871311L (en) SWITTERIONIC BICYCLIC RELATIONS AND THEIR SALTS, SOLVATES, HYDRATES AND ESTERS.
DK0951909T4 (en) Combination composition comprising an L-carnitine or an alkanoyl-L-carnitine, a glycosaminoglycan and / or component thereof
DK0553294T3 (en) The preparation of compositions for the treatment of cell proliferation disorders
NO983090L (en) Therapeutic compounds
DK0569383T3 (en) Low molecular weight, sulfated poly-beta-2,6-fructofuranosans and their use in the treatment of degenerative joint diseases
ES2122034T3 (en) DIPHOSPHATES OF CATECOLAMINS AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
DK0579765T3 (en) Method and Preparation for the Treatment of Herpes-Related Diseases
IT1279721B1 (en) ORTHOPEDIC PROSTHETIC DEVICE
DK0391224T3 (en) Drug and its use in the treatment of parasitoses
DK0625351T3 (en) Use of etofibrate and pharmaceutical preparations containing etofibrate for the treatment of diabetic angio- and retinopathy
ES1024446Y (en) DEVICE FOR THE PRACTICE OF ALPINISM OR CLIMBING.
NO901072D0 (en) PROCEDURE FOR FRACTIONING LIGNINES FROM VAPE EXPLODED LIGNOCELLULOSES WHICH PROVIDE FRACTIONS WITH DIFFERENT BUT REPRODUCABLE PROPERTIES, AND PROGRESS. TO TRANSFER THEM TO EACH OTHER AND THEREFORE PRODUCED PRODUCTS.